Use of Dose-dense EC Chemotherapy in Early Breast Cancer - Experience from Two London Hospitals

被引:0
|
作者
Amir, T. [1 ]
Chopra, N. [1 ]
Sheri, A. [1 ]
Newby, J. [1 ]
King, J. [1 ]
机构
[1] Royal Free NHS Fdn Trust, Royal Free Hosp, London, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E176 / E177
页数:3
相关论文
共 50 条
  • [21] Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer
    Razis, E
    Dimopoulus, AM
    Bafaloukos, D
    Papadimitriou, C
    Kalogera-Fountzila, A
    Kalofonos, H
    Briassoulis, E
    Samantas, E
    Keramopoulos, A
    Pavlidis, N
    Kosmidis, P
    Fountzilas, G
    CANCER INVESTIGATION, 2001, 19 (02) : 137 - 144
  • [22] Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer
    Tolaney, Sara M.
    Partridge, Ann H.
    Sheib, Rochelle G.
    Burstein, Harold J.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5330 - 5331
  • [23] CHEMOTHERAPY Dose-dense treatment for triple-negative breast cancer
    Amir, Eitan
    Ocana, Alberto
    Freedman, Orit
    Clemons, Mark
    Seruga, Bostjan
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (02) : 79 - 80
  • [24] Wiser Use of Dose-Dense Adjuvant Therapy in Breast Cancer
    Hillner, Bruce E.
    Smith, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) : 772 - 774
  • [25] Maternal and Neonatal Outcomes of Dose-Dense Chemotherapy for Breast Cancer in Pregnancy
    Cardonick, Elyce
    Gilmandyar, Dzhamala
    Somer, Robert A.
    OBSTETRICS AND GYNECOLOGY, 2012, 120 (06): : 1267 - 1272
  • [26] Dose-dense chemotherapy for breast cancer: what does the future hold?
    Morris, Patrick G.
    McArthur, Heather L.
    Hudis, Clifford
    Norton, Larry
    FUTURE ONCOLOGY, 2010, 6 (06) : 951 - 965
  • [27] Dose-dense chemotherapy versus conventional chemotherapy for early breast cancer: A systematic review with meta-analysis
    Duarte, Igor Lemos
    da Silveira Nogueira Lima, Joao Paulo
    Passos Lima, Carmen Silvia
    Sasse, Andre Deeke
    BREAST, 2012, 21 (03): : 343 - 349
  • [28] Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)
    Moebus, Volker
    Lueck, Hans-Joachim
    Ladda, Ekkehart
    Klare, Peter
    Schmidt, Marcus
    Schneeweiss, Andreas
    Grischke, Eva-Maria
    Wachsmann, Grischa
    Forstbauer, Helmut
    Untch, Michael
    Marme, Frederik
    Blohmer, Jens-Uwe
    Jackisch, Christian
    Huober, Jens
    Stickeler, Elmar
    Reinisch, Mattea
    Link, Theresa
    Sinn, Bruno, V
    Janni, Wolfgang
    Denkert, Carsten
    Furlanetto, Jenny
    Engels, Knut
    Solbach, Christine
    Schmatloch, Sabine
    Rey, Julia
    Burchardi, Nicole
    Loibl, Sibylle
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : 138 - 148
  • [29] Weekly dose-dense chemotherapy for ovarian cancer
    Tanday, Sanjay
    LANCET ONCOLOGY, 2016, 17 (04): : E138 - E138
  • [30] Neoadjuvant Dose-Dense and Dose-Intensified Chemotherapy in Breast Cancer - Review of the Literature
    Reinisch, Mattea
    Ataseven, Beyhan
    Kuemmel, Sherko
    BREAST CARE, 2016, 11 (01) : 13 - 20